𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PSY17 Cost-Utility Analysis of Immune Tolerance Induction (ITI) Therapy Versus On-Demand Treatment With Recombinant FVII (rFVIIa) for Hemophilia A With High Titer Inhibitors in Iran

✍ Scribed by Imani, A.; Rasekh, H.; Golestani, M.


Book ID
122241205
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
54 KB
Volume
15
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.